AMENDMENT NO. 2Note Conversion Agreement and Warrant Amendment • October 3rd, 2014 • VistaGen Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 3rd, 2014 Company Industry JurisdictionTHIS AMENDMENT NO. 2 TO AMENDED AND RESTATED NOTE CONVERSION AGREEMENT AND WARRANT AMENDMENT (this “Agreement”) is entered into on September 30, 2014, by and between VistaGen Therapeutics, Inc., a Nevada corporation (the “Company”), and Platinum Long Term Growth VII, LLC, a Delaware limited liability company (“Platinum”).